K
Pasithea Therapeutics Corp D
D
KTTA
0.74540
USD
-0.05
(-6.50%)
مغلق
حجم التداول
300
الربح لكل سهم
0
العائد الربحي
-
P/E
-0
حجم السوق
5,548,442
العنوان: Pasithea Therapeutics Corp
القطاع: Healthcare
الصناعة: Biotechnology
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).